XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Retained Earnings (Accumulated Deficit)
Balance (in shares) at Jun. 30, 2021   35,795,844      
Balance at Jun. 30, 2021 $ 17,046 $ 1,790 $ 25,102 $ 9,543 $ (19,389)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (43,224)       (43,224)
Foreign currency translation (217)     (217)  
Issuance of common stock, net of offering costs (in shares)   9,295,618      
Issuance of common stock, net of offering costs 37,185 $ 465 36,720    
Stock-based compensation 854   854    
Net restricted stock activity (in shares)   413,593      
Net restricted stock activity (525) $ 20 (545)    
Balance (in shares) at Mar. 31, 2022   45,505,055      
Balance at Mar. 31, 2022 11,119 $ 2,275 62,131 9,326 (62,613)
Balance (in shares) at Dec. 31, 2021   45,490,074      
Balance at Dec. 31, 2021 38,288 $ 2,277 61,601 9,105 (34,695)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (27,918)       (27,918)
Foreign currency translation 221     221  
Stock-based compensation 549   549    
Net restricted stock activity (in shares)   14,981      
Net restricted stock activity (21) $ (2) (19)    
Balance (in shares) at Mar. 31, 2022   45,505,055      
Balance at Mar. 31, 2022 $ 11,119 $ 2,275 62,131 9,326 (62,613)
Balance (in shares) at Jun. 30, 2022 45,510,245 45,510,245      
Balance at Jun. 30, 2022 $ (30,953) $ 2,276 62,562 9,455 (105,246)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (2,582)       (2,582)
Foreign currency translation (697)     (697)  
Stock-based compensation 1,522   1,522    
Net restricted stock activity (in shares)   54,428      
Net restricted stock activity $ (37) $ 2 (39)    
Balance (in shares) at Mar. 31, 2023 45,564,673 45,564,673      
Balance at Mar. 31, 2023 $ (32,747) $ 2,278 64,045 8,758 (107,828)
Balance (in shares) at Dec. 31, 2022   45,562,555      
Balance at Dec. 31, 2022 (31,635) $ 2,278 63,543 8,729 (106,185)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss (1,643)       (1,643)
Foreign currency translation 29     29  
Stock-based compensation 502   502    
Net restricted stock activity (in shares)   2,118      
Net restricted stock activity $ 0 $ 0 0    
Balance (in shares) at Mar. 31, 2023 45,564,673 45,564,673      
Balance at Mar. 31, 2023 $ (32,747) $ 2,278 $ 64,045 $ 8,758 $ (107,828)